Enduring efficacy of Botulinum toxin type A injection for refractory anterior knee pain

By Silbert Benjamin I.   Singer Barbara J.   Silbert Peter L.   Gibbons James T.   Singer Kevin P.  

Disability and Rehabilitation, Vol. 34, Iss. 1, 2012-01 ,pp. : 62-68

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127)

By Wallace Mark   Skowronski Roman   Khanna Sarita   Tudor Iulia Cristina   Thipphawong John  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 981-989

Informa Healthcare

Access to resources Recommend Favorite

Effect of Rehabilitation and Botulinum Toxin Injection on Gait in Chronic Stroke Patients: A Randomized Controlled Study

By  

Journal of Rehabilitation Medicine, Vol. 47, Iss. 1, 2015-01 ,pp. : 31-37

Medical Journals Limited

Access to resources Recommend Favorite

Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double‐blind and randomized placebo‐controlled study

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 641-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ultrasonographic Guided Botulinum Toxin Type a for Plantar Fasciitis: An Outcome-Based Investigation for Treating Pain and Gait Changes

By Huang Yung-Cheng   Wei Shun-Hwa   Wang Hsing-Kuo   Lieu Fu-Kong  

Journal of Rehabilitation Medicine, Vol. 42, Iss. 2, 2010-02 ,pp. : 136-140

Medical Journals Limited

Access to resources Recommend Favorite